Sugar Addiction and BED: Elucidating Pathological Mechanisms and Therapeutic Strategies

Open Access

Issue		BIO Web Conf. Volume 237, 2026 2026 8^th International Conference on Biotechnology and Biomedicine (ICBB 2026)


Article Number		01009
Number of page(s)		11
Section		Molecular and Cellular Pathophysiology
DOI		https://doi.org/10.1051/bioconf/202623701009
Published online		10 June 2026

AVITIA G C, LOYA MéNDEZ Y, PORTILLO REYES V, et al. Cravings, sugar and fat consumption as determinant factors of obesity in young adults in Juarez City [J]. Nutricion hospitalaria, 2018, 35(4): 833–40. [Google Scholar]
NOVELLE M G, DIéGUEZ C. Food Addiction and Binge Eating: Lessons Learned from Animal Models [J]. Nutrients, 2018, 10(1). [Google Scholar]
MOKHTARI F, TAGHAVI M, MASHAYEKH M. An Efficient Combination Therapy with Lisdexamfetamine Dimesylate and Topiramate in Improving Binge Eating Scale & Metabolic Profile in Binge Eating Disorder: A Randomized Control Trial [J]. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2024, 22(3): 493–501. [Google Scholar]
VOLKOW N D, MICHAELIDES M, BALER R. The Neuroscience of Drug Reward and Addiction [J]. Physiological reviews, 2019, 99(4): 2115–40. [Google Scholar]
PURSEY K M, YOKUM S, BRAIN K, et al. Neural Responses in Addictive Eating: a Systematic Review [J]. Current Addiction Reports, 2024, 11(2): 173–90. [Google Scholar]
KESSLER R M, HUTSON P H, HERMAN B K, et al. The neurobiological basis of binge-eating disorder [J]. Neuroscience and biobehavioral reviews, 2016, 63: 223–38. [Google Scholar]
WANG G J, VOLKOW N D, THANOS P K, et al. Imaging of brain dopamine pathways: implications for understanding obesity [J]. Journal of addiction medicine, 2009, 3(1): 8–18. [Google Scholar]
WALENDA A, BOGUSZ K, KOPERA M, et al. Emotion regulation in binge eating disorder [J]. Psychiatria polska, 2021, 55(6): 1433–48. [Google Scholar]
HIMMERICH H, BENTLEY J, MCELROY S L. Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases [J]. CNS drugs, 2024, 38(9): 697–718. [Google Scholar]
NATIONAL COLLABORATING CENTRE FOR MENTAL H. National Institute for Health and Clinical Excellence: Guidance [M]. Eating Disorders: Core Interventions in the Treatment and Management of Anorexia Nervosa, Bulimia Nervosa and Related Eating Disorders. Leicester (UK); British Psychological Society (UK) Copyright © 2004, The British Psychological Society & The Royal College of Psychiatrists. 2004. [Google Scholar]
GRILO C M, JUARASCIO A. Binge-Eating Disorder Interventions: Review, Current Status, and Implications [J]. Current obesity reports, 2023, 12(3): 406–16. [Google Scholar]
SOLMI M, MONACO F, HøJLUND M, et al. Outcomes in people with eating disorders: a transdiagnostic and disorder-specific systematic review, meta-analysis and multivariable meta-regression analysis [J]. World psychiatry : official journal of the World Psychiatric Association (WPA), 2024, 23(1): 124–38. [Google Scholar]
DAVIS H, ATTIA E. Pharmacotherapy of eating disorders [J]. Current opinion in psychiatry, 2017, 30(6): 452–7. [Google Scholar]
CRONE C, FOCHTMANN L J, ATTIA E, et al. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders [J]. The American journal of psychiatry, 2023, 180(2): 167–71. [Google Scholar]
HEAL D J, SMITH S L. Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacology [J]. Journal of psychopharmacology (Oxford, England), 2022, 36(6): 680–703. [Google Scholar]
DE SILVA P N. Are sweetened drinks a gateway to alcohol, opiate and stimulant addiction? Summary of evidence and therapeutic strategies [J]. Medical hypotheses, 2020, 135: 109469. [Google Scholar]
LEE A A, OWYANG C. Sugars, Sweet Taste Receptors, and Brain Responses [J]. Nutrients, 2017, 9(7). [Google Scholar]
QIN D, QI J, SHI F, et al. About Sugar Addiction [J]. Brain and behavior, 2025, 15(7): e70338. [Google Scholar]
YU X, DESRIVIèRES S. Altered anticipatory brain responses in eating disorders: A neuroimaging meta-analysis [J]. European eating disorders review : the journal of the Eating Disorders Association, 2023, 31(3): 363–76. [Google Scholar]
HAYNOS A F, CAMCHONG J, PEARSON C M, et al. Resting State Hypoconnectivity of Reward Networks in Binge Eating Disorder [J]. Cerebral cortex (New York, NY : 1991), 2021, 31(5): 2494–504. [Google Scholar]
KNUTSON B, GREER S M. Anticipatory affect: neural correlates and consequences for choice [J]. Philosophical transactions of the Royal Society of London Series B, Biological sciences, 2008, 363(1511): 3771–86. [Google Scholar]
BALODIS I M, KOBER H, WORHUNSKY P D, et al. Monetary reward processing in obese individuals with and without binge eating disorder [J]. Biological psychiatry, 2013, 73(9): 877–86. [Google Scholar]
SKANDALI N, MAJURI J, JOUTSA J, et al. The neural substrates of risky rewards and losses in healthy volunteers and patient groups: a PET imaging study [J]. Psychol Med, 2022, 52(14): 3280–8. [Google Scholar]
HARTOGSVELD B, QUAEDFLIEG C, VAN RUITENBEEK P, et al. Volume and Connectivity Differences in Brain Networks Associated with Cognitive Constructs of Binge Eating [J]. eNeuro, 2022, 9(1). [Google Scholar]
AHN J, LEE D, LEE J E, et al. Orbitofrontal cortex functional connectivity changes in patients with binge eating disorder and bulimia nervosa [J]. PloS one, 2022, 17(12): e0279577. [Google Scholar]
NEVEU R, NEVEU D, CARRIER E, et al. Goal Directed and Self-Control Systems in Bulimia Nervosa: An fMRI Study [J]. EBioMedicine, 2018, 34: 214–22. [Google Scholar]
ALIZADEH PAHLAVANI H. Possible role of exercise therapy on depression: Effector neurotransmitters as key players [J]. Behavioural brain research, 2024, 459: 114791. [Google Scholar]
CONWAY S M, MIKATI M O, AL-HASANI R. Challenges and new opportunities for detecting endogenous opioid peptides in reward [J]. Addiction neuroscience, 2022, 2. [Google Scholar]
GIANNI A D, DE DONATIS D, VALENTE S, et al. Eating disorders: Do PET and SPECT have a role? A systematic review of the literature [J]. Psychiatry research Neuroimaging, 2020, 300: 111065. [Google Scholar]
HEAL D J, HALLAM M, PROW M, et al. Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder [J]. Journal of psychopharmacology (Oxford, England), 2017, 31(6): 770–83. [Google Scholar]
LUDWIG D S, EBBELING C B. The Carbohydrate-Insulin Model of Obesity: Beyond “Calories In, Calories Out” [J]. JAMA internal medicine, 2018, 178(8): 1098–103. [Google Scholar]
BROUWERS B, DE OLIVEIRA E M, MARTI-SOLANO M, et al. Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation [J]. Cell reports, 2021, 34(12): 108862. [Google Scholar]
WESTWATER M L, FLETCHER P C, ZIAUDDEEN H. Sugar addiction: the state of the science [J]. European journal of nutrition, 2016, 55(Suppl 2): 55–69. [Google Scholar]
DALTON M, BLUNDELL J, FINLAYSON G. Effect of BMI and binge eating on food reward and energy intake: further evidence for a binge eating subtype of obesity [J]. Obesity facts, 2013, 6(4): 348–59. [Google Scholar]
PURSEY K M, STANWELL P, GEARHARDT A N, et al. The prevalence of food addiction as assessed by the Yale Food Addiction Scale: a systematic review [J]. Nutrients, 2014, 6(10): 4552–90. [Google Scholar]
WINTERDAHL M, NOER O, ORLOWSKI D, et al. Sucrose intake lowers μ-opioid and dopamine D2/3 receptor availability in porcine brain [J]. Scientific reports, 2019, 9(1): 16918. [Google Scholar]
KäMMERER W. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine-A literature review [J]. Human psychopharmacology, 2024, 39(6): e2910. [Google Scholar]
YU Y, MILLER R, GROTH S W. A literature review of dopamine in binge eating [J]. Journal of eating disorders, 2022, 10(1): 11. [Google Scholar]
PRUCCOLI J, PARMEGGIANI A, CORDELLI D M, et al. The Role of the Noradrenergic System in Eating Disorders: A Systematic Review [J]. Int J Mol Sci, 2021, 22(20). [Google Scholar]
GRILO C M, IVEZAJ V, YURKOW S, et al. Lisdexamfetamine maintenance treatment for binge-eating disorder following successful treatments: randomized double-blind placebo-controlled trial [J]. Psychol Med, 2024, 54(12): 1–11. [Google Scholar]
GRIFFITHS K R, BOULET S, BARAKAT S, et al. Exploring bi-directional impacts of Lisdexamfetamine dimesylate on psychological comorbidities and quality of life in people with Binge Eating Disorder [J]. Journal of eating disorders, 2024, 12(1): 80. [Google Scholar]
MURPHY C E, WANG R C, MONTOY J C, et al. Effect of extended‐release naltrexone on alcohol consumption: a systematic review and meta‐analysis [J]. Addiction, 2021, 117(2): 271–81. [Google Scholar]
BURNETTE E M, NIETO S J, GRODIN E N, et al. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder [J]. Drugs, 2022, 82(3): 251–74. [Google Scholar]
STANCIL S L, YEH H-W, BRUCKS M G, et al. Potential biomarker of brain response to opioid antagonism in adolescents with eating disorders: a pilot study [J]. Frontiers in Psychiatry, 2023, 14. [Google Scholar]
WANG S-C, CHEN Y-C, CHEN S-J, et al. Alcohol Addiction, Gut Microbiota, and Alcoholism Treatment: A Review [J]. International Journal of Molecular Sciences, 2020, 21(17). [Google Scholar]
LIU J C, MA J D, MORELLO C M, et al. Naltrexone metabolism and concomitant drug concentrations in chronic pain patients [J]. Journal of analytical toxicology, 2014, 38(4): 212–7. [Google Scholar]
GRILO C M, LYDECKER J A, FINEBERG S K, et al. Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial [J]. American Journal of Psychiatry, 2022, 179(12): 927–37. [Google Scholar]
GRILO C M, LYDECKER J A, GUEORGUIEVA R. Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial [J]. Psychological Medicine, 2023, 53(16): 7775–84. [Google Scholar]
ELMALEH-SACHS A, SCHWARTZ J L, BRAMANTE C T, et al. Obesity Management in Adults: A Review [J]. Jama, 2023, 330(20): 2000–15. [Google Scholar]
MORAES C E F, HAY P, SICHIERI R, et al. Hyperpalatable Foods Consumption in a Representative Sample of the General Population in Brazil: Differences of Binge and Non-Binge Eating Meals [J]. Behavioral sciences (Basel, Switzerland), 2023, 13(2). [Google Scholar]
DRUCKER D J, PHILIPPE J, MOJSOV S, et al. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line [J]. Proceedings of the National Academy of Sciences of the United States of America, 1987, 84(10): 3434–8. [Google Scholar]
HSU T M, NOBLE E E, LIU C M, et al. A hippocampus to prefrontal cortex neural pathway inhibits food motivation through glucagon-like peptide-1 signaling [J]. Molecular psychiatry, 2018, 23(7): 1555–65. [Google Scholar]
LADENHEIM E E. Liraglutide and obesity: a review of the data so far [J]. Drug design, development and therapy, 2015, 9: 1867–75. [Google Scholar]
FRíAS J P, DAVIES M J, ROSENSTOCK J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes [J]. The New England journal of medicine, 2021, 385(6): 503–15. [Google Scholar]
NAESSéN S, CARLSTRöM K, HOLST J J, et al. Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal [J]. The American journal of clinical nutrition, 2011, 94(4): 967–72. [Google Scholar]
BLUNDELL J, FINLAYSON G, AXELSEN M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity [J]. Diabetes, obesity & metabolism, 2017, 19(9): 1242–51. [Google Scholar]
NICOLAU J, PUJOL A, TOFé S, et al. Short term effects of semaglutide on emotional eating and other abnormal eating patterns among subjects living with obesity [J]. Physiology & behavior, 2022, 257: 113967. [Google Scholar]
MCELROY S L, HUDSON J I, MITCHELL J E, et al. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial [J]. JAMA psychiatry, 2015, 72(3): 235–46. [Google Scholar]
MCELROY S L, GUERDJIKOVA A I, MORI N, et al. Psychopharmacologic treatment of eating disorders: emerging findings [J]. Current psychiatry reports, 2015, 17(5): 35. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.